Humanized anti-human-PD-1 antibody and methods of using them for cancer treatment
US12331118B2 · kind B2 · utility
0Cited by
4References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 2, 2022 |
| Grant date | Jun 17, 2025 |
| Priority date | — |
| Expiry date | Sep 2, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described herein are humanized anti-PD-1 antibodies, nucleic acids encoding such, and uses thereof in enhancing immune responses by activating T cells and treating diseases such as cancer and an infectious disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.